314 related articles for article (PubMed ID: 32197914)
21. Cytokine and molecular analyses of intraocular lymphoma.
Ohta K; Sano K; Imai H; Kikuchi T
Ocul Immunol Inflamm; 2009; 17(3):142-7. PubMed ID: 19585355
[TBL] [Abstract][Full Text] [Related]
22. Serial changes in the aqueous IL-10 level after intravitreal methotrexate injection as an indicator of primary vitreoretinal lymphoma recurrence.
Park YG; Park WK; Kim RY; Kim M; Park YH
Sci Rep; 2020 Oct; 10(1):15992. PubMed ID: 33009434
[TBL] [Abstract][Full Text] [Related]
23. Cytokine profile in human eyes: contribution of a new cytokine combination for differential diagnosis between intraocular lymphoma or uveitis.
Fisson S; Ouakrim H; Touitou V; Baudet S; Ben Abdelwahed R; Donnou S; Miloudi A; Galand C; Bodaghi B; Lehoang P; Brissard M; Le Garff-Tavernier M; Fridman WH; Sautès-Fridman C; Cassoux N; Merle-Béral H
PLoS One; 2013; 8(2):e52385. PubMed ID: 23405064
[TBL] [Abstract][Full Text] [Related]
24. CLINICAL FEATURES, DIAGNOSTIC SIGNIFICANCE, AND PROGNOSIS OF VITREORETINAL LYMPHOMA IN YOUNG PATIENTS.
Liu S; Gu J; Zhang T; Ping B; Zhou M; Huang X; Jiang R; Xu G; Chang Q
Retina; 2021 Dec; 41(12):2596-2604. PubMed ID: 34173362
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis of intraocular lymphoma by polymerase chain reaction analysis and cytokine profiling of the vitreous fluid.
Sugita S; Takase H; Sugamoto Y; Arai A; Miura O; Mochizuki M
Jpn J Ophthalmol; 2009 May; 53(3):209-14. PubMed ID: 19484437
[TBL] [Abstract][Full Text] [Related]
26. Prognosis, Risk Factors, and Clinical Features of Intraocular Recurrence in Primary Vitreoretinal Lymphoma.
Liu S; Jiang T; Gu J; Zhou X; Chen W; Ping B; Zhou Y; Zhang T; Huang X; Xu G; Chang Q
Ophthalmol Retina; 2024 Apr; 8(4):317-324. PubMed ID: 37918656
[TBL] [Abstract][Full Text] [Related]
27. Distinct Profiles of Soluble Cytokine Receptors Between B-Cell Vitreoretinal Lymphoma and Uveitis.
Takeda A; Yoshikawa H; Fukuhara T; Hikita S; Hijioka K; Otomo T; Arita R; Hisatomi T; Kimura K; Yoshida S; Kawano Y; Sonoda KH; Ishibashi T
Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7516-23. PubMed ID: 26595610
[TBL] [Abstract][Full Text] [Related]
28. Clinical Characteristics of Primary Vitreoretinal Lymphoma in an Indian Population.
Mahajan S; Nijhawan R; Rajwanshi A; Karkhur S; Mulkutar S; Dogra M; Lal V; Gupta V; Gupta A
Ocul Immunol Inflamm; 2017 Oct; 25(5):633-638. PubMed ID: 27003620
[TBL] [Abstract][Full Text] [Related]
29. DEVELOPMENT OF EPSTEIN-BARR VIRUS UVEITIS AFTER REMISSION OF PRIMARY VITREORETINAL LYMPHOMA.
Chahal BS; Rasmussen S; White VA; Forooghian F
Retin Cases Brief Rep; 2016; 10(2):131-3. PubMed ID: 26267526
[TBL] [Abstract][Full Text] [Related]
30. MYD88 L265P MUTATION DETECTION IN THE AQUEOUS HUMOR OF PATIENTS WITH VITREORETINAL LYMPHOMA.
Miserocchi E; Ferreri AJM; Giuffrè C; Cangi MG; Francaviglia I; Calimeri T; Ponzoni M; Pecciarini L; Bandello FM; Modorati GM
Retina; 2019 Apr; 39(4):679-684. PubMed ID: 30204732
[TBL] [Abstract][Full Text] [Related]
31. How we diagnose and treat vitreoretinal lymphoma.
Fend F; Ferreri AJ; Coupland SE
Br J Haematol; 2016 Jun; 173(5):680-92. PubMed ID: 27133587
[TBL] [Abstract][Full Text] [Related]
32. Primary Vitreoretinal Lymphoma in HIV Infection.
Steffen J; Coupland SE; Smith JR
Ocul Immunol Inflamm; 2021 Apr; 29(3):621-627. PubMed ID: 32453669
[No Abstract] [Full Text] [Related]
33. Distinct microRNA-155 expression in the vitreous of patients with primary vitreoretinal lymphoma and uveitis.
Tuo J; Shen D; Yang HH; Chan CC
Am J Ophthalmol; 2014 Mar; 157(3):728-34. PubMed ID: 24345320
[TBL] [Abstract][Full Text] [Related]
34. Vitreous evaluation: a diagnostic challenge.
Mehta M; Rasheed RA; Duker J; Reichel E; Feinberg E; Husain D; Foster CS; Laver NV
Ophthalmology; 2015 Mar; 122(3):531-7. PubMed ID: 25439597
[TBL] [Abstract][Full Text] [Related]
35. Combined cellular and soluble mediator analysis for improved diagnosis of vitreoretinal lymphoma.
de Hoog J; Dik WA; Lu L; Heezen KC; Ten Berge JC; Swagemakers SMA; van der Spek PJ; van Dongen JJM; van der Velden VHJ; Rothova A; Langerak AW
Acta Ophthalmol; 2019 Sep; 97(6):626-632. PubMed ID: 30688042
[TBL] [Abstract][Full Text] [Related]
36. Development of Vitreoretinal Lymphoma in a Patient with Sarcoid Uveitis.
Wartique L; Jamilloux Y; De Parisot De Bernecourt A; Kodjikian L; Ghesquieres H; Ide C; Sève P
Ocul Immunol Inflamm; 2020 May; 28(4):647-650. PubMed ID: 31268740
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic efficacy of cell block method for vitreoretinal lymphoma.
Kase S; Namba K; Iwata D; Mizuuchi K; Kitaichi N; Tagawa Y; Okada-Kanno H; Matsuno Y; Ishida S
Diagn Pathol; 2016 Mar; 11():29. PubMed ID: 26987877
[TBL] [Abstract][Full Text] [Related]
38. Two cases of primary vitreoretinal lymphoma: a diagnostic challenge : The supporting role of multimodal imaging in the diagnosis of primary vitreoretinal lymphoma.
Morara M; Foschi F; Veronese C; Torrazza C; Bacci F; Stefoni V; Ciardella PA
Int Ophthalmol; 2018 Feb; 38(1):353-361. PubMed ID: 28039672
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic pars plana vitrectomy and aqueous analyses in patients with uveitis of unknown cause.
Oahalou A; Schellekens PA; de Groot-Mijnes JD; Rothova A
Retina; 2014 Jan; 34(1):108-14. PubMed ID: 23619637
[TBL] [Abstract][Full Text] [Related]
40. Primary vitreoretinal natural killer/T-cell lymphoma with breast involvement: A case report and review of the literature.
Gao S; Zhou Y; Jin X; Lin Z; Zhong Y; Shen X
Surv Ophthalmol; 2019; 64(2):225-232. PubMed ID: 30321569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
